Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Activation of nitric oxide synthase by β2‐adrenoceptors in human umbilical vein endothelium in vitro

Open access
Ferro, Albert, Queen, Lindsay R, Priest, Rachel M, Xu, Biao, Ritter, James M, Poston, Lucilla, Ward, Jeremy P T · 1999 · British Journal of Pharmacology

Abstract

Some animal studies suggest that β‐adrenoceptor‐mediated vasorelaxation is in part mediated through nitric oxide (NO) release. Furthermore, in humans, we have recently shown that forearm blood flow is increased by infusion of β 2‐adrenergic agonists into the brachial artery, and the nitric oxide synthase (NOS) inhibitor N G‐monomethyl‐L‐arginine (L‐NMMA) inhibits this response. The purpose of the present study was to determine whether stimulation of human umbilical vein endothelial β‐adrenoceptors causes vasorelaxation and nitric oxide generation, and whether this might be mediated by cyclic adenosine‐3′,5′‐monophosphate (cyclic AMP). Vasorelaxant responses were determined in umbilical vein rings to the nonselective β‐adrenergic agonist isoprenaline and to the cyclic AMP analogue dibutyryl cyclic AMP, following precontraction with prostaglandin F 2α. NOS activity was measured in cultured human umbilical vein endothelial cells (HUVEC) by the conversion of [3 H]‐L‐arginine to [3 H]‐L‐citrulline, and adenylyl cyclase activity by the conversion of [α‐32 P]‐ATP to [32 P]‐cyclic AMP. Isoprenaline relaxed umbilical vein rings, and this vasorelaxation was abolished by β 2‐ (but not β 1‐) adrenergic blockage, and by endothelium removal or 1 m M L‐NMMA. In addition, vasorelaxant responses to dibutyryl cyclic AMP were inhibited by 1 m M L‐NMMA, with a reduction in E max from 90.0±9.3% to 50.5±9.9% (P<0.05). Isoprenaline 1 μ M increased NOS activity in HUVEC (34.0±5.9% above basal, P<0.001). Furthermore, isoprenaline increased adenylyl cyclase activity in a concentration‐dependent manner; this response was inhibited by β 2 (but not β 1‐) adrenergic blockade. Forskolin 1 μ M and dibutyryl cyclic AMP 1 m M each increased NOS activity in HUVEC, to a degree similar to isoprenaline 1 μ M. The increase in L‐arginine to L‐citrulline conversion observed with each agent was abolished by co‐incubation with NOS inhibitors. These results indicate that endothelial β 2‐adrenergic stimulation and cyclic AMP elevation activate the L‐arginine/NO system, and give rise to vasorelaxation, in human umbilical vein. British Journal of Pharmacology (1999) 126, 1872–1880; doi:10.1038/sj.bjp.0702512

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0702512

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 161

Metadata

Authors
Ferro, A., Queen, L. R., Priest, R. M., Xu, B., Ritter, J. M., Poston, L., & Ward, J. P. T.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1999-04
Volume
126
Issue
8
Pages
1872-1880
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2051197841
Cited by
161
References
1
FWCI
3.63
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activation of nitric oxide synthase by β2‐adrenoceptors in human umbilical vein endothelium in vitro. https://app.cochat.ai/papers/10.1038/sj.bjp.0702512
The paper
Ferro, A., Queen, L. R., Priest, R. M., Xu, B., Ritter, J. M., Poston, L., & Ward, J. P. T. (1999). Activation of nitric oxide synthase by β2‐adrenoceptors in human umbilical vein endothelium in vitro. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0702512

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.